Production (Stage)
Eton Pharmaceuticals, Inc.
ETON
$14.30
-$0.21-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.57M | -598.00K | 627.00K | -3.04M | -811.00K |
| Total Depreciation and Amortization | 1.01M | 355.00K | 278.00K | 261.00K | 234.00K |
| Total Amortization of Deferred Charges | 294.00K | 986.00K | 39.00K | 59.00K | 25.00K |
| Total Other Non-Cash Items | 2.36M | 852.00K | 722.00K | 840.00K | 839.00K |
| Change in Net Operating Assets | -4.00K | -2.36M | 1.29M | 3.14M | -2.76M |
| Cash from Operations | 2.09M | -765.00K | 2.95M | 1.26M | -2.47M |
| Capital Expenditure | -- | -12.00K | 0.00 | 0.00 | -14.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -30.00M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -8.12M | 0.00 | 0.00 | -1.87M |
| Cash from Investing | -- | -38.13M | 0.00 | 0.00 | -1.88M |
| Total Debt Issued | -- | 25.31M | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | -385.00K | -385.00K | -385.00K |
| Issuance of Common Stock | 394.00K | 8.26M | 0.00 | 169.00K | 7.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 394.00K | 33.57M | -385.00K | -216.00K | -378.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.48M | -5.33M | 2.57M | 1.04M | -4.73M |